0001209191-17-057697.txt : 20171023 0001209191-17-057697.hdr.sgml : 20171023 20171023065612 ACCESSION NUMBER: 0001209191-17-057697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171019 FILED AS OF DATE: 20171023 DATE AS OF CHANGE: 20171023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLATTERY JOSEPH P CENTRAL INDEX KEY: 0001246530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 171148220 MAIL ADDRESS: STREET 1: C/O SAFESTITCH MEDICAL, INC. STREET 2: 635 DAVID DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-19 0 0000876378 TRANSENTERIX INC. TRXC 0001246530 SLATTERY JOSEPH P C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP and CFO Common Stock 2017-10-19 4 M 0 150000 1.00 A 794365 D Common Stock 2017-10-19 4 F 0 23391 3.73 D 770974 D Common Stock 25000 I By IRA Series B Warrants 1.00 2017-10-19 4 M 0 150000 0.00 D 2017-05-03 2022-05-03 Common Stock 150000 0 D On October 19, 2017, the reporting person exercised, via a cashless exercise option, Series B warrants to acquire 150,000 shares of common stock of TransEnterix, Inc. (the "Company"), par value $0.001 per share, for an exercise price of $1.00 per share. In connection with the reporting person's cashless exercise of Series B warrants, the Company withheld 23,391 of the shares to satisfy the exercise price and issued to the reporting person the remaining 126,609 shares. The volume weighted average price of the common stock calculated as set forth in the Series B warrant was $3.7329. /s/ Joshua Weingard as attorney-in-fact for Joseph Slattery 2017-10-23